Global Alzheimer's Disease Treatments Market Research Report 2023

Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.

The global Alzheimer's Disease Treatments market was valued at US$ 3680.4 million in 2022 and is anticipated to reach US$ 4024.3 million by 2029, witnessing a CAGR of 1.5% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The major players in global Alzheimer’s Disease Drug market include Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson, Lundbeck, etc. The top 3 players hold over 60% of global shares. Europe and North America are main markets, they occupy over 70% of the global market. Memantine and Donepezil are the main types, with a share about 70%. Early to Moderate Stages is the key application, which covers over 55% shares.

This report aims to provide a comprehensive presentation of the global market for Alzheimer's Disease Treatments, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alzheimer's Disease Treatments.

The Alzheimer's Disease Treatments market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Alzheimer's Disease Treatments market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Alzheimer's Disease Treatments companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Alzheimer's Disease Treatments Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Cholinesterase Inhibitors

1.2.3 NMDA Antagonists

1.3 Market by Application

1.3.1 Global Alzheimer's Disease Treatments Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospitals

1.3.3 Diagnostic Laboratories

1.3.4 Research and Academic Laboratories

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Alzheimer's Disease Treatments Market Perspective (2018-2029)

2.2 Alzheimer's Disease Treatments Growth Trends by Region

2.2.1 Global Alzheimer's Disease Treatments Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Alzheimer's Disease Treatments Historic Market Size by Region (2018-2023)

2.2.3 Alzheimer's Disease Treatments Forecasted Market Size by Region (2024-2029)

2.3 Alzheimer's Disease Treatments Market Dynamics

2.3.1 Alzheimer's Disease Treatments Industry Trends

2.3.2 Alzheimer's Disease Treatments Market Drivers

2.3.3 Alzheimer's Disease Treatments Market Challenges

2.3.4 Alzheimer's Disease Treatments Market Restraints

3.1 Global Top Alzheimer's Disease Treatments Players by Revenue

3.1.1 Global Top Alzheimer's Disease Treatments Players by Revenue (2018-2023)

3.1.2 Global Alzheimer's Disease Treatments Revenue Market Share by Players (2018-2023)

3.2 Global Alzheimer's Disease Treatments Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Alzheimer's Disease Treatments Revenue

3.4 Global Alzheimer's Disease Treatments Market Concentration Ratio

3.4.1 Global Alzheimer's Disease Treatments Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Alzheimer's Disease Treatments Revenue in 2022

3.5 Alzheimer's Disease Treatments Key Players Head office and Area Served

3.6 Key Players Alzheimer's Disease Treatments Product Solution and Service

3.7 Date of Enter into Alzheimer's Disease Treatments Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Alzheimer's Disease Treatments Historic Market Size by Type (2018-2023)

4.2 Global Alzheimer's Disease Treatments Forecasted Market Size by Type (2024-2029)

5.1 Global Alzheimer's Disease Treatments Historic Market Size by Application (2018-2023)

5.2 Global Alzheimer's Disease Treatments Forecasted Market Size by Application (2024-2029)

6.1 North America Alzheimer's Disease Treatments Market Size (2018-2029)

6.2 North America Alzheimer's Disease Treatments Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Alzheimer's Disease Treatments Market Size by Country (2018-2023)

6.4 North America Alzheimer's Disease Treatments Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Alzheimer's Disease Treatments Market Size (2018-2029)

7.2 Europe Alzheimer's Disease Treatments Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Alzheimer's Disease Treatments Market Size by Country (2018-2023)

7.4 Europe Alzheimer's Disease Treatments Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Alzheimer's Disease Treatments Market Size (2018-2029)

8.2 Asia-Pacific Alzheimer's Disease Treatments Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Alzheimer's Disease Treatments Market Size by Region (2018-2023)

8.4 Asia-Pacific Alzheimer's Disease Treatments Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Alzheimer's Disease Treatments Market Size (2018-2029)

9.2 Latin America Alzheimer's Disease Treatments Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Alzheimer's Disease Treatments Market Size by Country (2018-2023)

9.4 Latin America Alzheimer's Disease Treatments Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Alzheimer's Disease Treatments Market Size (2018-2029)

10.2 Middle East & Africa Alzheimer's Disease Treatments Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Alzheimer's Disease Treatments Market Size by Country (2018-2023)

10.4 Middle East & Africa Alzheimer's Disease Treatments Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Eisai

11.1.1 Eisai Company Detail

11.1.2 Eisai Business Overview

11.1.3 Eisai Alzheimer's Disease Treatments Introduction

11.1.4 Eisai Revenue in Alzheimer's Disease Treatments Business (2018-2023)

11.1.5 Eisai Recent Development

11.2 Forest Laboratories

11.2.1 Forest Laboratories Company Detail

11.2.2 Forest Laboratories Business Overview

11.2.3 Forest Laboratories Alzheimer's Disease Treatments Introduction

11.2.4 Forest Laboratories Revenue in Alzheimer's Disease Treatments Business (2018-2023)

11.2.5 Forest Laboratories Recent Development

11.3 H. Lundbeck

11.3.1 H. Lundbeck Company Detail

11.3.2 H. Lundbeck Business Overview

11.3.3 H. Lundbeck Alzheimer's Disease Treatments Introduction

11.3.4 H. Lundbeck Revenue in Alzheimer's Disease Treatments Business (2018-2023)

11.3.5 H. Lundbeck Recent Development

11.4 Johnson and Johnson

11.4.1 Johnson and Johnson Company Detail

11.4.2 Johnson and Johnson Business Overview

11.4.3 Johnson and Johnson Alzheimer's Disease Treatments Introduction

11.4.4 Johnson and Johnson Revenue in Alzheimer's Disease Treatments Business (2018-2023)

11.4.5 Johnson and Johnson Recent Development

11.5 Merz Pharma

11.5.1 Merz Pharma Company Detail

11.5.2 Merz Pharma Business Overview

11.5.3 Merz Pharma Alzheimer's Disease Treatments Introduction

11.5.4 Merz Pharma Revenue in Alzheimer's Disease Treatments Business (2018-2023)

11.5.5 Merz Pharma Recent Development

11.6 Novartis

11.6.1 Novartis Company Detail

11.6.2 Novartis Business Overview

11.6.3 Novartis Alzheimer's Disease Treatments Introduction

11.6.4 Novartis Revenue in Alzheimer's Disease Treatments Business (2018-2023)

11.6.5 Novartis Recent Development

11.7 Pfizer

11.7.1 Pfizer Company Detail

11.7.2 Pfizer Business Overview

11.7.3 Pfizer Alzheimer's Disease Treatments Introduction

11.7.4 Pfizer Revenue in Alzheimer's Disease Treatments Business (2018-2023)

11.7.5 Pfizer Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Alzheimer's Disease Treatments Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Cholinesterase Inhibitors

    Table 3. Key Players of NMDA Antagonists

    Table 4. Global Alzheimer's Disease Treatments Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 5. Global Alzheimer's Disease Treatments Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Alzheimer's Disease Treatments Market Size by Region (2018-2023) & (US$ Million)

    Table 7. Global Alzheimer's Disease Treatments Market Share by Region (2018-2023)

    Table 8. Global Alzheimer's Disease Treatments Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 9. Global Alzheimer's Disease Treatments Market Share by Region (2024-2029)

    Table 10. Alzheimer's Disease Treatments Market Trends

    Table 11. Alzheimer's Disease Treatments Market Drivers

    Table 12. Alzheimer's Disease Treatments Market Challenges

    Table 13. Alzheimer's Disease Treatments Market Restraints

    Table 14. Global Alzheimer's Disease Treatments Revenue by Players (2018-2023) & (US$ Million)

    Table 15. Global Alzheimer's Disease Treatments Market Share by Players (2018-2023)

    Table 16. Global Top Alzheimer's Disease Treatments Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Treatments as of 2022)

    Table 17. Ranking of Global Top Alzheimer's Disease Treatments Companies by Revenue (US$ Million) in 2022

    Table 18. Global 5 Largest Players Market Share by Alzheimer's Disease Treatments Revenue (CR5 and HHI) & (2018-2023)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Alzheimer's Disease Treatments Product Solution and Service

    Table 21. Date of Enter into Alzheimer's Disease Treatments Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Alzheimer's Disease Treatments Market Size by Type (2018-2023) & (US$ Million)

    Table 24. Global Alzheimer's Disease Treatments Revenue Market Share by Type (2018-2023)

    Table 25. Global Alzheimer's Disease Treatments Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 26. Global Alzheimer's Disease Treatments Revenue Market Share by Type (2024-2029)

    Table 27. Global Alzheimer's Disease Treatments Market Size by Application (2018-2023) & (US$ Million)

    Table 28. Global Alzheimer's Disease Treatments Revenue Market Share by Application (2018-2023)

    Table 29. Global Alzheimer's Disease Treatments Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 30. Global Alzheimer's Disease Treatments Revenue Market Share by Application (2024-2029)

    Table 31. North America Alzheimer's Disease Treatments Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 32. North America Alzheimer's Disease Treatments Market Size by Country (2018-2023) & (US$ Million)

    Table 33. North America Alzheimer's Disease Treatments Market Size by Country (2024-2029) & (US$ Million)

    Table 34. Europe Alzheimer's Disease Treatments Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. Europe Alzheimer's Disease Treatments Market Size by Country (2018-2023) & (US$ Million)

    Table 36. Europe Alzheimer's Disease Treatments Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Asia-Pacific Alzheimer's Disease Treatments Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Asia-Pacific Alzheimer's Disease Treatments Market Size by Region (2018-2023) & (US$ Million)

    Table 39. Asia-Pacific Alzheimer's Disease Treatments Market Size by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Alzheimer's Disease Treatments Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Latin America Alzheimer's Disease Treatments Market Size by Country (2018-2023) & (US$ Million)

    Table 42. Latin America Alzheimer's Disease Treatments Market Size by Country (2024-2029) & (US$ Million)

    Table 43. Middle East & Africa Alzheimer's Disease Treatments Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Middle East & Africa Alzheimer's Disease Treatments Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Middle East & Africa Alzheimer's Disease Treatments Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Eisai Company Detail

    Table 47. Eisai Business Overview

    Table 48. Eisai Alzheimer's Disease Treatments Product

    Table 49. Eisai Revenue in Alzheimer's Disease Treatments Business (2018-2023) & (US$ Million)

    Table 50. Eisai Recent Development

    Table 51. Forest Laboratories Company Detail

    Table 52. Forest Laboratories Business Overview

    Table 53. Forest Laboratories Alzheimer's Disease Treatments Product

    Table 54. Forest Laboratories Revenue in Alzheimer's Disease Treatments Business (2018-2023) & (US$ Million)

    Table 55. Forest Laboratories Recent Development

    Table 56. H. Lundbeck Company Detail

    Table 57. H. Lundbeck Business Overview

    Table 58. H. Lundbeck Alzheimer's Disease Treatments Product

    Table 59. H. Lundbeck Revenue in Alzheimer's Disease Treatments Business (2018-2023) & (US$ Million)

    Table 60. H. Lundbeck Recent Development

    Table 61. Johnson and Johnson Company Detail

    Table 62. Johnson and Johnson Business Overview

    Table 63. Johnson and Johnson Alzheimer's Disease Treatments Product

    Table 64. Johnson and Johnson Revenue in Alzheimer's Disease Treatments Business (2018-2023) & (US$ Million)

    Table 65. Johnson and Johnson Recent Development

    Table 66. Merz Pharma Company Detail

    Table 67. Merz Pharma Business Overview

    Table 68. Merz Pharma Alzheimer's Disease Treatments Product

    Table 69. Merz Pharma Revenue in Alzheimer's Disease Treatments Business (2018-2023) & (US$ Million)

    Table 70. Merz Pharma Recent Development

    Table 71. Novartis Company Detail

    Table 72. Novartis Business Overview

    Table 73. Novartis Alzheimer's Disease Treatments Product

    Table 74. Novartis Revenue in Alzheimer's Disease Treatments Business (2018-2023) & (US$ Million)

    Table 75. Novartis Recent Development

    Table 76. Pfizer Company Detail

    Table 77. Pfizer Business Overview

    Table 78. Pfizer Alzheimer's Disease Treatments Product

    Table 79. Pfizer Revenue in Alzheimer's Disease Treatments Business (2018-2023) & (US$ Million)

    Table 80. Pfizer Recent Development

    Table 81. Research Programs/Design for This Report

    Table 82. Key Data Information from Secondary Sources

    Table 83. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Alzheimer's Disease Treatments Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Alzheimer's Disease Treatments Market Share by Type: 2022 VS 2029

    Figure 3. Cholinesterase Inhibitors Features

    Figure 4. NMDA Antagonists Features

    Figure 5. Global Alzheimer's Disease Treatments Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 6. Global Alzheimer's Disease Treatments Market Share by Application: 2022 VS 2029

    Figure 7. Hospitals Case Studies

    Figure 8. Diagnostic Laboratories Case Studies

    Figure 9. Research and Academic Laboratories Case Studies

    Figure 10. Others Case Studies

    Figure 11. Alzheimer's Disease Treatments Report Years Considered

    Figure 12. Global Alzheimer's Disease Treatments Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 13. Global Alzheimer's Disease Treatments Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 14. Global Alzheimer's Disease Treatments Market Share by Region: 2022 VS 2029

    Figure 15. Global Alzheimer's Disease Treatments Market Share by Players in 2022

    Figure 16. Global Top Alzheimer's Disease Treatments Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Treatments as of 2022)

    Figure 17. The Top 10 and 5 Players Market Share by Alzheimer's Disease Treatments Revenue in 2022

    Figure 18. North America Alzheimer's Disease Treatments Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 19. North America Alzheimer's Disease Treatments Market Share by Country (2018-2029)

    Figure 20. United States Alzheimer's Disease Treatments Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Canada Alzheimer's Disease Treatments Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Europe Alzheimer's Disease Treatments Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Alzheimer's Disease Treatments Market Share by Country (2018-2029)

    Figure 24. Germany Alzheimer's Disease Treatments Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. France Alzheimer's Disease Treatments Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. U.K. Alzheimer's Disease Treatments Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Italy Alzheimer's Disease Treatments Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Russia Alzheimer's Disease Treatments Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Nordic Countries Alzheimer's Disease Treatments Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Asia-Pacific Alzheimer's Disease Treatments Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Alzheimer's Disease Treatments Market Share by Region (2018-2029)

    Figure 32. China Alzheimer's Disease Treatments Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Japan Alzheimer's Disease Treatments Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. South Korea Alzheimer's Disease Treatments Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Southeast Asia Alzheimer's Disease Treatments Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. India Alzheimer's Disease Treatments Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Australia Alzheimer's Disease Treatments Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Latin America Alzheimer's Disease Treatments Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Alzheimer's Disease Treatments Market Share by Country (2018-2029)

    Figure 40. Mexico Alzheimer's Disease Treatments Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Brazil Alzheimer's Disease Treatments Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Middle East & Africa Alzheimer's Disease Treatments Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Alzheimer's Disease Treatments Market Share by Country (2018-2029)

    Figure 44. Turkey Alzheimer's Disease Treatments Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Saudi Arabia Alzheimer's Disease Treatments Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Eisai Revenue Growth Rate in Alzheimer's Disease Treatments Business (2018-2023)

    Figure 47. Forest Laboratories Revenue Growth Rate in Alzheimer's Disease Treatments Business (2018-2023)

    Figure 48. H. Lundbeck Revenue Growth Rate in Alzheimer's Disease Treatments Business (2018-2023)

    Figure 49. Johnson and Johnson Revenue Growth Rate in Alzheimer's Disease Treatments Business (2018-2023)

    Figure 50. Merz Pharma Revenue Growth Rate in Alzheimer's Disease Treatments Business (2018-2023)

    Figure 51. Novartis Revenue Growth Rate in Alzheimer's Disease Treatments Business (2018-2023)

    Figure 52. Pfizer Revenue Growth Rate in Alzheimer's Disease Treatments Business (2018-2023)

    Figure 53. Bottom-up and Top-down Approaches for This Report

    Figure 54. Data Triangulation

    Figure 55. Key Executives Interviewed